We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Christopher Barbieri

Christopher E Barbieri MD, PhD

Associate Professor of Urology, Weill Cornell Medicine, NewYork-Presbyterian Hospital, New York, New York

Christopher Barbieri, MD, PhD is Associate Professor of Urology and Associate Professor of Cell and Developmental Biology at Weill Cornell Medicine and NewYork-Presbyterian Hospital.  He is a urologic surgeon who takes care of patients with prostate cancer, and whose long-term goal is using molecular information to improve the care of prostate cancer patients. Dr. Barbieri received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees.  He then completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College.  Dr. Barbieri’s research focuses on improving molecular classification of prostate cancer and identifying novel drivers, defining the signaling pathways and biology underlying distinct subtypes of the disease, and exposing new therapeutic avenues. His work has led to recognition and awards from the Prostate Cancer Foundation, Urology Care Foundation, and Damon Runyon Cancer Research Foundation, and his laboratory is funded by the National Cancer Institute.